Novavax, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 10.08 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.66B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Details
| Name | Novavax, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 749 |
| Founded | 1987 |
| Ipo Date | 1995-12-05 |
| Ceo | John Jacobs |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US6700024010 |
| Cusip | 670002401 |
| Cik | 0001000694 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| John Charles Jacobs M.B.A. | President, Chief Executive Officer and Director |
| James Patrick Kelly C.F.A. | Executive Vice President, Chief Financial Officer and Treasurer |
| Mark J. Casey Esq., J.D. | Executive Vice President, Chief Legal Officer and Corporate Secretary |
| Elaine O'Hara | Executive Vice President and Chief Strategy Officer |
| Richard P. Crowley | Executive Vice President and Chief Operating Officer |
| Naina Zaman | Director of Investor Relations |
| Troy Morgan Esq., J.D. | Senior Vice President, Deputy General Counsel and Chief Compliance Officer |
| Erika S. Trahan | Associate Director of Investor and Public Relations |
| Ian J. Watkins | Executive Vice President and Chief Human Resources Officer |
| Silvia Taylor M.B.A. | Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden |
Contact
| Address | 21 Firstfield Road, Gaithersburg, Maryland 20878, United States |
| Phone | 240 268 2000 |
| Website | https://www.novavax.com |